Skip to main content
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. — Investor Relations & Filings

Ticker · MCRB ISIN · US81750R2013 LEI · 549300GMXBE5NUWISF13 US Manufacturing
Open in API
Filings indexed 668 across all filing types
Latest filing 2023-04-14 Proxy Solicitation & In…
Country US United States of America
Listing US MCRB

About Seres Therapeutics, Inc.

https://www.serestherapeutics.com/

Seres Therapeutics, Inc. is a commercial-stage biotechnology company developing microbiome-based therapeutics. The company's platform creates a novel class of biological drugs, known as live biotherapeutics, which consist of rationally selected consortia of live bacteria. These therapies are designed to modulate the functional properties of the gastrointestinal microbiome to treat and prevent diseases. Seres' development programs target medically vulnerable patient populations, with a focus on preventing bacterial bloodstream and antimicrobial-resistant (AMR) infections, as well as treating gastrointestinal-related immune diseases.

Recent filings

Filing Released Lang Actions
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, as indicated by the header and the text. It is related to the solicitation of proxies for the Annual Meeting of Stockholders of Seres Therapeutics, Inc. The document includes detailed information about the meeting agenda, proposals to be voted on, board recommendations, and voting instructions. It is not an announcement of voting results, nor is it a report of financial results or management discussion. It is a formal proxy solicitation document used to inform shareholders about matters to be voted on at the annual meeting. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the full proxy statement, not just an announcement or a brief summary.
2023-04-14 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-04-06 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC. Form S-8 is used to register securities to be offered under employee benefit plans such as stock purchase plans and incentive award plans. The text includes details about the registration of additional shares under employee stock plans, references to indemnification of directors and officers, and exhibits related to corporate governance documents and legal opinions. There are no financial statements or earnings data, nor is this a report of financial performance or management discussion. It is a regulatory filing related to securities registration for employee benefit plans. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Capital Update. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories.
2023-03-07 English
10-K
Annual Report FY 2022
2023-03-07 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 7, 2023, by Seres Therapeutics, Inc. It announces the company's financial results for the quarter and year ended December 31, 2022, and provides operational updates. The text explicitly states that the full press release with financial results is furnished as an exhibit and is 'furnished, and not filed,' indicating this document is an announcement rather than the full earnings report itself. The document length is 3735 characters, which is relatively short and consistent with an earnings release announcement rather than a full report. The key section is Item 2.02, 'Results of Operations and Financial Condition,' which is typically used for earnings releases. Therefore, this document is best classified as an Earnings Release (ER).
2023-03-07 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-02-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.